271 related articles for article (PubMed ID: 23457048)
21. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
Kershaw G; Jayakodi D; Dunkley S
Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
[TBL] [Abstract][Full Text] [Related]
22. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
Barrio J; Peris V; Asensio I; Molina I; López F; García V
Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of bleeding disorder in a child.
Sarnaik A; Kamat D; Kannikeswaran N
Clin Pediatr (Phila); 2010 May; 49(5):422-31. PubMed ID: 20118083
[TBL] [Abstract][Full Text] [Related]
24. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of clotting screens.
Thorell SE; Nash MJ; Thachil J
Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
[TBL] [Abstract][Full Text] [Related]
26. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
Burns ER; Goldberg SN; Wenz B
Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin time and partial thromboplastin time assay considerations.
Ng VL
Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of coagulation time: PT and APTT].
Ramakers C; van der Heul C; van Wijk EM
Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
[TBL] [Abstract][Full Text] [Related]
29. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
[TBL] [Abstract][Full Text] [Related]
30. Automated mixing studies and pattern recognition for the laboratory diagnosis of a prolonged activated partial thromboplastin time using an automated coagulation analyzer.
Ohsaka A; Ishii K; Yamamoto T; Horii T; Tabe Y
Thromb Res; 2011 Jul; 128(1):86-91. PubMed ID: 21397297
[TBL] [Abstract][Full Text] [Related]
31. Coronary bypass surgery in patients with circulating lupus anticoagulant.
Kelly JP; Thomas L; Moulder PV; Webb WR
Ann Thorac Surg; 1985 Sep; 40(3):261-3. PubMed ID: 3929705
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care testing of neonatal coagulation.
Tan K; Booth D; Newell SJ; Dear PR; Hughes C; Richards M
Clin Lab Haematol; 2006 Apr; 28(2):117-21. PubMed ID: 16630216
[TBL] [Abstract][Full Text] [Related]
33. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
[TBL] [Abstract][Full Text] [Related]
34. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
35. [Exploration of hemostasis in current practice].
Aiach M; Gaussem P
Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
[TBL] [Abstract][Full Text] [Related]
36. Prolonged partial thromboplastin time: To mix or not to mix - is that the question?
Yates SG; Fitts E; De Simone N; Sarode R
Transfus Apher Sci; 2019 Feb; 58(1):39-42. PubMed ID: 30497857
[TBL] [Abstract][Full Text] [Related]
37. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
38. Similar mechanism of various lupus anticoagulants.
Exner T
Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
[TBL] [Abstract][Full Text] [Related]
39. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
40. Laboratory support in the diagnosis of coagulation disorders.
Giddings JC; Peake IR
Clin Haematol; 1985 Jun; 14(2):571-95. PubMed ID: 3899445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
